Table 4 Immunopathological data between IgAN and IgAVN patients
Immune complexes | Grade of deposition | IgAN | IgAVN | P value |
|---|---|---|---|---|
IgG | - | 187(74%) | 55(77.5%) | 0.343 |
1+ | 52(20.5%) | 15(21.1%) | ||
2+, 3+ | 14(5.5%) | 1(1.4%) | ||
IgM | - | 17(6.7%) | 4(5.6%) | 0.877 |
1+ | 161(63.6%) | 44(62%) | ||
2+, 3+ | 75(29.6%) | 23(32.4%) | ||
IgA | 1+ | 9(3.6%) | 1(1.4%) | 0.241 |
2+ | 36(14.2) | 5(7%) | ||
3+ | 183(72.3%) | 55(77.5%) | ||
4+ | 25(9.9%) | 10(14.1%) | ||
C3 | - | 12(4.7%) | 5(7%) | 0.042 |
1+ | 62 (24.5%) | 27(38%) | ||
2+, 3+ | 179(70.8%) | 39(55%) | ||
C1q | - | 230(90.9%) | 66(93%) | 0.682 |
1+ | 21(8.3%) | 4(5.6%) | ||
2+, 3+ | 2(0.8%) | 1(1.4%) | ||
FIB | - | 180(71%) | 29(41%) | < 0.001 |
1+ | 26(10%) | 9(13) | ||
2+, 3+ | 47(19%) | 33(46%) |